Pillstats
Rx only · Tablet · Oral

Dasatinib

Brands: Phyrago · Sprycel · Dasatinib

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US42 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)475342
US makers7 labelers
Packages48
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$40.69$81.39$122.08$162.78Dec 2025Mar 2026Jul 2026
$139.366
Latest avg · Jul 22, 2026
+361%
Since Dec 17, 2025
7
Active US suppliers
38%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.6K3.2K4.8K6.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.9K
Rx · 2026 Q1
156K
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown12SUPPLYING
Zydus Lifesciences Limitedunknown6SUPPLYING
E.R. Squibb & Sons, L.L.C.unknown6SUPPLYING
Lupin Pharmaceuticals,Inc.unknown6SUPPLYING
Prasco Laboratoriesunknown6SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown6SUPPLYING
Cycle Pharmaceuticals Ltd.unknown6SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.